BPH - Benign Prostatic Enlargement - Results from #60

Testosterone Replacement Therapy and LUTS/BPH. What is the Evidence?- Beyond the Abstract July 13, 2016

Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study - Beyond the Abstract March 30, 2016

Benign Prostatic Hyperplasia Treatment with New Physiotherapeutic Device - Beyond the Abstract March 24, 2016

Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement - Beyond the Abstract July 30, 2015

Reoperation after holmium laser enucleation of the prostate for management of benign prostate hyperplasia: assessment of risk factors with time to event analysis - Beyond the Abstract July 22, 2015

Holmium laser enucleation and photoselective vaporisation of the prostate for patients with benign prostatic hyperplasia and chronic urinary retention, "Beyond the Abstract," by Christopher D. Jaeger, MD June 16, 2015

Trends and utilization of laser prostatectomy in ambulatory surgical procedures for the treatment of BPH, "Beyond the Abstract," by Vannita Simma-Chiang and Bilal Chughtai April 13, 2015

General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia, "Beyond the Abstract," by Jae Heon Kim, MD, PhD April 2, 2015

Preliminary results in 13 patients treated with prostatic artery embolization for benign prostatic hyperplasia, "Beyond the Abstract," by Alberto Balderi, Maurizio Grosso, and Giuseppe Arena April 1, 2015

A population-based survey looking at the prevalence of lower urinary tract symptoms in Korean men aged 40 years or older, "Beyond the Abstract," by Tae Heon Kim, MD February 24, 2015

Analysis of the prevalence of inflammation and benign prostatic hyperplasia in Asian and Caucasian men at autopsy, "Beyond the Abstract," by Alexandre R. Zlotta February 20, 2015

Plasmakinetic vaporization vs plasmakinetic resection to treat benign prostatic hyperplasia, "Beyond the Abstract," by Mert Ali Karadag, MD January 23, 2015

Results from the Turkish Society of Andrology male sexual health study group on the prevalence of male pelvic dysfunction, "Beyond the Abstract," by Muammer Kendirci, MD November 20, 2014

Incidental prostate cancer in transurethral resection of the prostate specimens, "Beyond the Abstract," by Claire Dunphy and Bilal Chughtai October 23, 2014

The impact of abdominal aortic calcification and visceral fat obesity on lower urinary tract symptoms in patients with benign prostatic hyperplasia, "Beyond the Abstract," by Seiji Matsumoto, MD, PhD October 7, 2014

Sexual dysfunction, high Gleason grade prostate cancer, and depression: The dark side of therapy with 5α-reductase inhibitors, "Beyond the Abstract," by Abdulmaged M. Traish, PhD October 1, 2014

Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function, "Beyond the Abstract," by Mauro Gacci, MD, et al September 16, 2014

A double-blind placebo-controlled randomized clinical trial using tolterodine to relieve urinary symptoms following transurethral resection of the prostate, "Beyond the Abstract," by Yousef Rezaei September 3, 2014

Non-invasive urodynamics predicts outcome prior to surgery for obstruction in benign prostatic hyperplasia, "Beyond the Abstract," by Giovanni Losco, MB, ChB(Dist), FRACS(Urol) July 30, 2014

The association of lower urinary tract symptoms, depression, and suicidal ideation, "Beyond the Abstract," by Thomas W. Gaither, BS; Sarah D. Blaschko, MD; and Benjamin N. Breyer, MD July 18, 2014

Page 4 of 6